6 research outputs found
Kinetic Study on Oxidation of Thiodipropionic Acid by Iron (III)- bipyridine Complex
Iron(III)-bipyridine complex was prepared andcharacterized by UV-Visible spectrophotometer. Kineticstudy was carried out by using this iron(III)-bipyridinewith thiodipropionic acid in aqueous acetonitrile solution.The reaction was optimized by studying the effect onsubstrate, solvent, oxidant, acidity and temperature. Firstorder, second order rate constants and activationparameters were calculated. The above reaction wasfound to be second order and proceeded through electrontransfer from thiodipropionic acid to iron(III)-bipyridinecomplex. The product was characterized and confirmedby IR and NMR spectroscopy.Keywords: Thiodipropionic acid, Iron(III)-bipyridine complex,kinetic study of Iron(III)-bipyridyl complexes
Designing Biomass Rice Husk Silica as an Efficient Catalyst for the Synthesis of Biofuel Additive n-Butyl Levulinate
Green biomimetic silver nanoparticles utilizing the red algae Amphiroa rigida and its potent antibacterial, cytotoxicity and larvicidal efficiency
Factors associated with unexplained sudden deaths among adults aged 18-45 years in India – A multicentric matched case–control study
Background & objectives: In view of anecdotal reports of sudden unexplained deaths in India's apparently healthy young adults, linking to coronavirus disease 2019 (COVID-19) infection or vaccination, we determined the factors associated with such deaths in individuals aged 18-45 years through a multicentric matched case–control study.
Methods: This study was conducted through participation of 47 tertiary care hospitals across India. Cases were apparently healthy individuals aged 18-45 years without any known co-morbidity, who suddenly (<24 h of hospitalization or seen apparently healthy 24 h before death) died of unexplained causes during 1st October 2021-31st March 2023. Four controls were included per case matched for age, gender and neighborhood. We interviewed/perused records to collect data on COVID-19 vaccination/infection and post-COVID-19 conditions, family history of sudden death, smoking, recreational drug use, alcohol frequency and binge drinking and vigorous-intensity physical activity two days before death/interviews. We developed regression models considering COVID-19 vaccination ≤42 days before outcome, any vaccine received anytime and vaccine doses to compute an adjusted matched odds ratio (aOR) with 95 per cent confidence interval (CI).
Results: Seven hundred twenty nine cases and 2916 controls were included in the analysis. Receipt of at least one dose of COVID-19 vaccine lowered the odds [aOR (95% CI)] for unexplained sudden death [0.58 (0.37, 0.92)], whereas past COVID-19 hospitalization [3.8 (1.36, 10.61)], family history of sudden death [2.53 (1.52, 4.21)], binge drinking 48 h before death/interview [5.29 (2.57, 10.89)], use of recreational drug/substance [2.92 (1.1, 7.71)] and performing vigorous-intensity physical activity 48 h before death/interview [3.7 (1.36, 10.05)] were positively associated. Two doses lowered the odds of unexplained sudden death [0.51 (0.28, 0.91)], whereas single dose did not.
Interpretation & conclusions: COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India. Past COVID-19 hospitalization, family history of sudden death and certain lifestyle behaviors increased the likelihood of unexplained sudden death